Stockscreener 앱 받기
77.38
2.61%
1.87
전일 마감가:
$75.51
열려 있는:
$76.51
하루 거래량:
12.05M
Relative Volume:
1.18
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.22%
1개월 성능:
-11.07%
6개월 성능:
-21.16%
1년 성능:
-7.49%
1일 변동 폭
$76.39
$77.80
1주일 범위
$73.94
$77.80
52주 변동 폭
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
XBI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
77.36 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
258.10 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
524.96 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
527.39 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
206.90 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
442.45 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf 주식(XBI)의 최신 뉴스
Alliancebernstein L.P. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
O Shaughnessy Asset Management LLC Has $65,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech stocks to own amid market volatility – Piper Sandler (XBI:NYSEARCA) - Seeking Alpha
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets - Yahoo Finance
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
How the (XBI) price action is used to our Advantage - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
11 Stocks to Buy After the Biotech Bloodbath - Barron's
Wednesday's ETF Movers: XBI, PICK - Nasdaq
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies - MSN
XBI Crosses Critical Technical Indicator - Nasdaq
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Reuters
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard - TradingView
Bank of New York Mellon Corp Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Trump administration cancels $12 billion in funding to state health departments (XBI:NYSEARCA) - Seeking Alpha
Proficio Capital Partners LLC Buys 5,225 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Sequoia Financial Advisors LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
How Is Biogen's Stock Performance Compared to Other Biotech Stocks? - TradingView
(XBI) Investment Report - Stock Traders Daily
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Armenian Reporter
Assetmark Inc. Sells 588,528 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Atria Investments Inc Buys 1,043 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
Steward Partners Investment Advisory LLC Sells 814 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
(XBI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Top-rated biotechs with negative enterprise values - MSN
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
Van ECK Associates Corp Makes New $1.50 Million Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Vontobel Holding Ltd. Has $621,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Allspring Global Investments Holdings LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Mirae Asset Global Investments Co. Ltd. Has $299,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
How to Take Advantage of moves in (XBI) - Stock Traders Daily
Unlocking the Mystery of Smart Beta: A Deep Dive into the iShares Biotechnology ETF - Clinique Bio
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - TradingView
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Can Health Care ETFs Aid Your Portfolio? - ETF Trends
Spdr Biotech Etf (XBI) 재무 분석
Spdr Biotech Etf (XBI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.84%
1.13%
자본화:
|
볼륨(24시간):